Go Pro
→ These gold assets are priced for $1,800 gold [it's over $4,000] (From Golden Portfolio) (Ad)tc pixel Free IPHYF Stock Alerts

Innate Pharma (IPHYF) Short Interest Ratio & Short Volume

Innate Pharma logo
$1.65 0.00 (0.00%)
As of 08/25/2026
Compare

Innate Pharma Short Interest Overview

As of August 14, 2026, Innate Pharma (IPHYF) had a short interest of 16,627 shares sold short, representing 0.03% of the public float. This marks a 341.03% increase in short interest since the prior report. The short interest ratio (days to cover) is 1,000.0, meaning it would take 1,000.0 days of the average trading volume of 3 shares to cover all short positions.

Current Short Interest
16,627 shares
Previous Short Interest
3,770 shares
Change Vs. Previous Month
341.03%
Dollar Volume Sold Short
$27.43 thousand
Short Interest Ratio
1,000.0 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
83,830,000 shares
Short Percent of Float
0.03%
Today's Trading Volume
0 shares
Average Trading Volume
3 shares
Today's Volume Vs. Average
0%
Short Selling Innate Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IPHYF Short Interest Over Time

IPHYF Days to Cover Over Time

IPHYF Percentage of Float Shorted Over Time

Innate Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/202616,627 shares $27.43 thousand +341.0%0.0%999.99 $1.65
7/31/20263,770 shares $6.22 thousand -51.8%0.0%0 $1.65
7/15/20267,824 shares $12.91 thousand -5.2%0.0%0 $1.65
6/30/20268,252 shares $13.62 thousand +77.0%0.0%0 $1.65
6/15/20264,661 shares $7.69 thousand +9,222.0%0.0%0 $1.65
5/29/202650 shares $82.50 -99.8%0.0%0.03 $1.65
5/15/202623,016 shares $51.79 thousand +100.0%0.0%639.33 $2.25
3/31/20262,210 shares $3.03 thousand -67.3%0.0%130 $1.37
3/13/20266,765 shares $14.58 thousand +883.3%0.0%0 $2.16
2/27/2026688 shares $1.48 thousand +1,363.8%0.0%229.33 $2.16
2/13/202647 shares $101.29 -97.6%0.0%4.7 $2.16
1/30/20261,989 shares $4.29 thousand +7,856.0%0.0%0 $2.16
1/15/202625 shares $53.88 -99.8%0.0%0 $2.16
12/31/202511,101 shares $23.92 thousand +94.8%0.0%616.72 $2.16
12/15/20255,699 shares $10.86 thousand +100.0%0.0%14.84 $1.91
9/30/20252,900 shares $5.80 thousand -73.6%N/A0 $2.00
9/15/202511,000 shares $22 thousand +746.2%N/A0.8 $2.00
8/31/20251,300 shares $2.68 thousand No Change0.0%0 $2.06
7/31/2025100 shares $131.00 No Change0.0%0 $1.31
7/15/2025100 shares $131.00 No ChangeN/A1 $1.31
6/30/2025100 shares $195.00 -91.7%0.0%1 $1.95
6/15/20251,200 shares $2.08 thousand +1,100.0%0.0%6 $1.74
5/31/2025100 shares $145.00 -99.5%0.0%0 $1.45
5/15/202521,000 shares $30.45 thousand +6,900.0%0.0%210 $1.45
4/30/2025300 shares $435.00 -92.9%N/A0 $1.45
4/15/20254,200 shares $6.09 thousand +100.0%0.0%3.2 $1.45
3/31/20252,100 shares $6.09 thousand +133.3%0.0%21 $2.90
3/15/2025900 shares $2.61 thousand No Change0.0%0 $2.90
2/15/20251,600 shares $4.64 thousand +220.0%0.0%0 $2.90
1/31/2025500 shares $1.45 thousand No ChangeN/A0 $2.90
1/15/2025500 shares $1.45 thousand No ChangeN/A0 $2.90
12/31/2024500 shares $1.45 thousand -94.1%N/A5 $2.90
12/15/20248,400 shares $24.36 thousand +425.0%N/A21 $2.90
11/30/20241,600 shares $2.05 thousand -61.9%N/A0 $1.28
11/15/20244,200 shares $5.38 thousand -14.3%N/A42 $1.28
10/31/20244,900 shares $11.00 thousand -17.0%N/A0 $2.25
10/15/20245,900 shares $13.25 thousand -1.7%N/A0 $2.25
9/30/20246,000 shares $13.47 thousand +22.5%N/A10 $2.25
9/15/20244,900 shares $11.27 thousand No ChangeN/A0 $2.30
8/31/20244,900 shares $11.27 thousand -21.0%N/A24.5 $2.30
Bezos… DOOMED (Ad)

A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.tc pixel

Watch James Altucher's free video breakdown before the September 25 deadline.
8/15/20246,200 shares $13.02 thousand -8.8%N/A12.4 $2.10
7/31/20246,800 shares $13.12 thousand +23.6%N/A0 $1.93
7/15/20245,500 shares $10.62 thousand No ChangeN/A55 $1.93
6/30/20245,500 shares $13.70 thousand -30.4%N/A0 $2.49
6/15/20247,900 shares $19.67 thousand +43.6%N/A7.2 $2.49
5/31/20245,500 shares $12.10 thousand No ChangeN/A55 $2.20
5/15/20245,500 shares $12.10 thousand -6.8%N/A2.5 $2.20
4/30/20245,900 shares $15.64 thousand -1.7%N/A0 $2.65
4/15/20246,000 shares $15.90 thousand +3.5%N/A60 $2.65
3/31/20245,800 shares $14.96 thousand No ChangeN/A29 $2.58
3/15/20245,800 shares $14.15 thousand +1.8%N/A58 $2.44
2/29/20245,700 shares $16.19 thousand No ChangeN/A0 $2.84
2/15/20245,700 shares $16.19 thousand -5.0%N/A0 $2.84
1/15/20244,800 shares $13.63 thousand +108.7%N/A48 $2.84
12/31/20232,300 shares $6.53 thousand -48.9%N/A4.5 $2.84
12/15/20234,500 shares $11.48 thousand +650.0%N/A22.5 $2.55
11/30/2023600 shares $1.43 thousand +500.0%N/A0 $2.39
11/15/2023100 shares $239.00 No ChangeN/A1 $2.39
10/15/20239,800 shares $22.63 thousand +9,700.0%N/A19.6 $2.31
9/30/2023100 shares $300.00 No ChangeN/A0 $3.00
8/31/202311,600 shares $33.70 thousand +11,500.0%N/A43.5 $2.91
8/15/2023100 shares $291.00 -75.0%N/A1 $2.91
7/31/2023400 shares $1.20 thousand No ChangeN/A4 $2.99
7/15/2023400 shares $1.23 thousand +33.3%N/A4 $3.08
6/30/2023300 shares $1.01 thousand +200.0%N/A3 $3.36
6/15/2023100 shares $334.00 -80.0%N/A0.3 $3.34
5/31/2023500 shares $1.47 thousand +400.0%N/A0 $2.93
5/15/2023100 shares $293.00 -75.0%N/A1 $2.93
4/30/2023400 shares $1.15 thousand +100.0%N/A4 $2.88
4/15/2023200 shares $542.00 -97.8%N/A0 $2.71
3/31/20239,200 shares $24.93 thousand -27.6%N/A92 $2.71
3/15/202312,700 shares $39.50 thousand +1,487.5%N/A63.5 $3.11
2/28/2023800 shares $2.34 thousand +14.3%N/A8 $2.93
2/15/2023700 shares $2.41 thousand -95.5%N/A0 $3.44
1/31/202315,700 shares $54.01 thousand +15,600.0%N/A52.3 $3.44
1/15/2023100 shares $347.00 -97.1%N/A0.3 $3.47
12/30/20223,500 shares $11.45 thousand -60.7%N/A0.7 $3.27
12/15/20228,900 shares $20.65 thousand +8,800.0%N/A22.3 $2.32
11/30/2022100 shares $218.88 -90.9%N/A1 $2.19
11/15/20221,100 shares $2.52 thousand -80.4%N/A1.1 $2.29
10/31/20225,600 shares $11.70 thousand +30.2%N/A56 $2.09
10/15/20224,300 shares $8.90 thousand +4,200.0%N/A2.3 $2.07
9/30/2022100 shares $193.00 -66.7%N/A1 $1.93
9/15/2022300 shares $780.00 -97.7%N/A1.5 $2.60
8/31/202212,800 shares $35.84 thousand +236.8%N/A8.5 $2.80
8/15/20223,800 shares $10.56 thousand +11.8%N/A12.7 $2.78
7/31/20223,400 shares $10.74 thousand +6.3%N/A34 $3.16
7/15/20223,200 shares $8.64 thousand -3.0%N/A32 $2.70
6/30/20223,300 shares $8.58 thousand -15.4%N/A1.2 $2.60
6/15/20223,900 shares $10.80 thousand -54.7%N/A39 $2.77
The retirement stock I'd buy before Nvidia today (Ad)

In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel

Get Marc Chaikin's free presentation on this overlooked AI stock now
5/31/20228,600 shares $24.34 thousand +34.4%N/A86 $2.83
5/15/20226,400 shares $18.11 thousand -4.5%N/A32 $2.83
4/30/20226,700 shares $18.39 thousand +8.1%N/A67 $2.75
4/15/20226,200 shares $18.91 thousand +51.2%N/A12.4 $3.05
3/31/20224,100 shares $14.19 thousand -93.9%N/A41 $3.46
3/15/202267,000 shares $241.87 thousand -10.8%N/A0 $3.61
2/28/202275,100 shares $271.11 thousand +1,004.4%N/A751 $3.61
2/15/20226,800 shares $25.23 thousand -70.0%N/A5.7 $3.71
1/31/202222,700 shares $85.58 thousand +57.6%N/A37.8 $3.77
1/15/202214,400 shares $62.64 thousand +5.1%N/A0 $4.35
12/31/202113,700 shares $59.60 thousand +407.4%N/A5.1 $4.35
12/15/20212,700 shares $13.74 thousand -52.6%N/A1.4 $5.09
11/30/20215,700 shares $28.62 thousand +1.8%N/A6.3 $5.02
11/15/20215,600 shares $28 thousand -51.7%N/A3.1 $5.00
10/29/202111,600 shares $65.66 thousand -6.5%N/A4.1 $5.66
10/15/202112,400 shares $73.16 thousand +63.2%N/A6.5 $5.90
9/30/20217,600 shares $47.50 thousand -26.2%N/A0.7 $6.25
9/15/202110,300 shares $58.50 thousand -94.6%N/A0.7 $5.68
8/31/2021191,300 shares $679.12 thousand -49.5%N/A956.5 $3.55

IPHYF Short Interest - Frequently Asked Questions

Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been covered or closed out. As of August 14th, investors have sold 16,627 shares of IPHYF short. 0.03% of Innate Pharma's shares are currently sold short. Learn More on Innate Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHYF shares currently have a short interest ratio of 1,000.0. Learn More on Innate Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.03% of Innate Pharma's floating shares are currently sold short.

Innate Pharma saw a increase in short interest during the month of August. As of August 14th, there was short interest totaling 16,627 shares, an increase of 341.0% from the previous total of 3,770 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.03% of Innate Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Innate Pharma: Prime Medicine, Inc. (23.00%), Maplight Therapeutics, Inc. (7.25%), Zura Bio Limited (13.62%), Kyverna Therapeutics, Inc. (16.68%), LogicBio Therapeutics, Inc. (1.94%), Evommune, Inc. (18.79%), C4 Therapeutics, Inc. (29.32%), Entera Bio Ltd. (0.62%), AgomAb Therapeutics NV (2.60%), Cabaletta Bio, Inc. (26.98%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling IPHYF is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHYF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHYF, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IPHYF:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:IPHYF is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Gold Explorer Sits Between Barrick’s Nevada Giants
Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...
Wall Street Logic | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...
Paradigm Press | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
The New Kings of Cantillon
In 1720, Richard Cantillon discovered that new money never spreads evenly through an economy. It reaches certa...
Porter & Company | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel